Lin RT, Gao JW, Yang YC, Chen XW, et al. Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers. J Hypertens 2025 Apr 22. doi: 10.1097/HJH.0000000000004037.
PMID: 40271773